Targeting replication stress in cancer therapy

被引:177
作者
da Costa, Alexandre Andre B. A. [1 ]
Chowdhury, Dipanjan [1 ]
Shapiro, Geoffrey I. [2 ]
D'Andrea, Alan D. [1 ,3 ]
Konstantinopoulos, Panagiotis A. [2 ]
机构
[1] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Ctr DNA Damage & Repair, Boston, MA 02115 USA
关键词
WEE1 INHIBITOR AZD1775; DNA-DAMAGE RESPONSE; CHECKPOINT KINASE 1; MYELOID-LEUKEMIA CELLS; SEROUS OVARIAN-CANCER; ADVANCED SOLID TUMORS; I DOSE-ESCALATION; PHASE-I; CHK1; INHIBITOR; ATR INHIBITOR;
D O I
10.1038/s41573-022-00558-5
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Replication stress is a major cause of genomic instability and a crucial vulnerability of cancer cells. This vulnerability can be therapeutically targeted by inhibiting kinases that coordinate the DNA damage response with cell cycle control, including ATR, CHK1, WEE1 and MYT1 checkpoint kinases. In addition, inhibiting the DNA damage response releases DNA fragments into the cytoplasm, eliciting an innate immune response. Therefore, several ATR, CHK1, WEE1 and MYT1 inhibitors are undergoing clinical evaluation as monotherapies or in combination with chemotherapy, poly[ADP-ribose]polymerase (PARP) inhibitors, or immune checkpoint inhibitors to capitalize on high replication stress, overcome therapeutic resistance and promote effective antitumour immunity. Here, we review current and emerging approaches for targeting replication stress in cancer, from preclinical and biomarker development to clinical trial evaluation.
引用
收藏
页码:38 / 58
页数:21
相关论文
共 215 条
[1]   Functional Genetic Screen Identifies Increased Sensitivity to WEE1 Inhibition in Cells with Defects in Fanconi Anemia and HR Pathways [J].
Aarts, Marieke ;
Bajrami, Ilirjana ;
Herrera-Abreu, Maria T. ;
Elliott, Richard ;
Brough, Rachel ;
Ashworth, Alan ;
Lord, Christopher J. ;
Turner, Nicholas C. .
MOLECULAR CANCER THERAPEUTICS, 2015, 14 (04) :865-876
[2]   Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1 [J].
Aarts, Marieke ;
Sharpe, Rachel ;
Garcia-Murillas, Isaac ;
Gevensleben, Heidrun ;
Hurd, Melissa S. ;
Shumway, Stuart D. ;
Toniatti, Carlo ;
Ashworth, Alan ;
Turner, Nicholas C. .
CANCER DISCOVERY, 2012, 2 (06) :524-539
[3]   Interim results from a phase II study of the ATR inhibitor ceralasertib in ARID1A-deficient and ARID1A-intact advanced solid tumor malignancies [J].
Aggarwal, R. ;
Umetsu, S. ;
Dhawan, M. ;
Grabowsky, J. ;
Carnevale, J. ;
Howell, M. ;
Wilch, L. ;
Chapman, J. ;
Alvarez, E. ;
Calabrese, S. ;
Smith, S. ;
Shah, N. ;
Dean, E. ;
Munster, P. ;
Collisson, E. .
ANNALS OF ONCOLOGY, 2021, 32 :S583-S583
[4]   Targeting the DNA replication stress phenotype of KRAS mutant cancer cells [J].
Al Zubaidi, Tara ;
Gehrisch, O. H. Fiete ;
Genois, Marie-Michelle ;
Liu, Qi ;
Lu, Shan ;
Kung, Jong ;
Xie, Yunhe ;
Schuemann, Jan ;
Lu, Hsiao-Ming ;
Hata, Aaron N. ;
Zou, Lee ;
Borgmann, Kerstin ;
Willers, Henning .
SCIENTIFIC REPORTS, 2021, 11 (01)
[5]  
Alimzhanov M., 2019, Cancer Research, V79, P2269, DOI [10.1158/1538-7445.AM2019-2269, DOI 10.1158/1538-7445.AM2019-2269]
[6]   A phase I/II first-in-human trial of oral SRA737 (a Chk1 inhibitor) given in combination with low-dose gemcitabine in subjects with advanced cancer. [J].
Banerji, Udai ;
Plummer, Elizabeth Ruth ;
Moreno, Victor ;
Ang, Joo Ern ;
Quinton, Amy ;
Drew, Yvette ;
Hernandez, Tatiana ;
Roda, Desamparados ;
Carter, Louise ;
Navarro, Alejandro ;
Kristeleit, Rebecca Sophie ;
Arkenau, Hendrik-Tobias ;
Sarker, Debashis ;
Castellano, Daniel E. ;
Walter, Harriet ;
Roxburgh, Patricia ;
Blagden, Sarah Patricia ;
Anthoney, Alan ;
Verdon, Ines ;
Jones, Robert Hugh .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[7]   Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints [J].
Bartkova, Jirina ;
Rezaei, Nousin ;
Liontos, Michalis ;
Karakaidos, Panagiotis ;
Kletsas, Dimitris ;
Issaeva, Natalia ;
Vassiliou, Leandros-Vassilios F. ;
Kolettas, Evangelos ;
Niforou, Katerina ;
Zoumpourlis, Vassilis C. ;
Takaoka, Munenori ;
Nakagawa, Hiroshi ;
Tort, Frederic ;
Fugger, Kasper ;
Johansson, Fredrik ;
Sehested, Maxwell ;
Andersen, Claus L. ;
Dyrskjot, Lars ;
Orntoft, Torben ;
Lukas, Jiri ;
Kittas, Christos ;
Helleday, Thomas ;
Halazonetis, Thanos D. ;
Bartek, Jiri ;
Gorgoulis, Vassilis G. .
NATURE, 2006, 444 (7119) :633-637
[8]   Cyclin-Dependent Kinase Suppression by WEE1 Kinase Protects the Genome through Control of Replication Initiation and Nucleotide Consumption [J].
Beck, Halfdan ;
Nahse-Kumpf, Viola ;
Larsen, Marie Sofie Yoo ;
O'Hanlon, Karen A. ;
Patzke, Sebastian ;
Holmberg, Christian ;
Mejlvang, Jakob ;
Groth, Anja ;
Nielsen, Olaf ;
Syljuasen, Randi G. ;
Sorensen, Claus Storgaard .
MOLECULAR AND CELLULAR BIOLOGY, 2012, 32 (20) :4226-4236
[9]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[10]   The Schizosaccharomyces pombe rad3 checkpoint gene [J].
Bentley, NJ ;
Holtzman, DA ;
Flaggs, G ;
Keegan, KS ;
DeMaggio, A ;
Ford, JC ;
Hoekstra, M ;
Carr, AM .
EMBO JOURNAL, 1996, 15 (23) :6641-6651